A recent study has revealed that a heightened level of CD38 expression in TILs promotes increases in the levels of Ki-67 in tumor cells, and that highly expressed CD38+ TILs independently predict shorter OS and PFS (47). This evidence concerns the gene CD38 and neoplasm.